Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism-Reference-Cited by-同舟云学术

Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism

Published:2018-08-01 Issue:8 Volume:3 Page:768
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Hundemer Gregory L.¹²,Curhan Gary C.¹²³,Yozamp Nicholas²,Wang Molin²³,Vaidya Anand²⁴

Affiliation:

1. Division of Renal Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

2. Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

3. Department of Epidemiology, Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts

4. Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.;Lavall;J Biol Chem,2014

2. Aldosterone promotes atrial fibrillation.;Reil;Eur Heart J,2012

3. Hyperaldosteronism induces left atrial systolic and diastolic dysfunction.;Reil;Am J Physiol Heart Circ Physiol,2016

4. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.;Tsai;J Am Coll Cardiol,2010

5. Arterial hypertension, atrial fibrillation, and hyperaldosteronism: the triple trouble.;Seccia;Hypertension,2017

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressed Renin Status is a Risk Factor for Cardiocerebrovascular Events in Bilateral Primary Aldosteronism Treated with Mineralocorticoid Receptor Antagonists;Endocrine Practice;2024-09

2. Utility of Adrenal Vein Sampling With and Without Ultra‐Low Dose ACTH Infusion in the Diagnostic Evaluation of Primary Aldosteronism;Endocrinology, Diabetes & Metabolism;2024-08-29

3. Rationality and implication of catheter-based adrenal ablation for bilateral primary aldosteronism;Hypertension Research;2024-08-08

4. Diagnostic Accuracy of Aldosterone and Renin Measurement by Chemiluminescence for Screening of Patients with Primary Aldosteronism;International Journal of Molecular Sciences;2024-08-02

5. Prevalence of unilateral hyperaldosteronism in primary aldosteronism: impact of a novel chemiluminescent immunoassay for measuring plasma aldosterone in Japan;Hypertension Research;2024-07-29